Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIPPV for High Altitude Pulmonary Edema
NCT04288219Unknown
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2020
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
Randomised, open-label trial in high altitude pulmonary edema (HAPE), sponsored by Massachusetts General Hospital. Primary endpoint: Oxygen saturation at 4 hours. Status: unknown.
02
Conditions
high altitude pulmonary edema (HAPE)
Beyond the preview
Go deeper on NCT04288219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04288219.